These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 26766734)

  • 1. Oncolytic viruses: finally delivering.
    Seymour LW; Fisher KD
    Br J Cancer; 2016 Feb; 114(4):357-61. PubMed ID: 26766734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virotherapy--cancer targeted pharmacology.
    Tedcastle A; Cawood R; Di Y; Fisher KD; Seymour LW
    Drug Discov Today; 2012 Mar; 17(5-6):215-20. PubMed ID: 22198165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential of tumour cells for delivering oncolytic viruses.
    Raykov Z; Rommelaere J
    Gene Ther; 2008 May; 15(10):704-10. PubMed ID: 18356816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncolytic viruses in the treatment of cancer: a review of current strategies.
    Zeyaullah M; Patro M; Ahmad I; Ibraheem K; Sultan P; Nehal M; Ali A
    Pathol Oncol Res; 2012 Oct; 18(4):771-81. PubMed ID: 22714538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncolytic Virotherapy by HSV.
    Watanabe D; Goshima F
    Adv Exp Med Biol; 2018; 1045():63-84. PubMed ID: 29896663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a versatile oncolytic virus platform for local intra-tumoural expression of therapeutic transgenes.
    Marino N; Illingworth S; Kodialbail P; Patel A; Calderon H; Lear R; Fisher KD; Champion BR; Brown ACN
    PLoS One; 2017; 12(5):e0177810. PubMed ID: 28542292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncolytic viruses as platform for multimodal cancer therapeutics: a promising land.
    Guo ZS; Bartlett DL
    Cancer Gene Ther; 2014 Jul; 21(7):261-3. PubMed ID: 25034971
    [No Abstract]   [Full Text] [Related]  

  • 8. Editorial: oncolytic viruses.
    Jia W
    Curr Pharm Biotechnol; 2012 Jul; 13(9):1731. PubMed ID: 22856874
    [No Abstract]   [Full Text] [Related]  

  • 9. Oncolytic viruses in cancer therapy.
    Vähä-Koskela MJ; Heikkilä JE; Hinkkanen AE
    Cancer Lett; 2007 Sep; 254(2):178-216. PubMed ID: 17383089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical development of oncolytic viruses in China.
    Liang M
    Curr Pharm Biotechnol; 2012 Jul; 13(9):1852-7. PubMed ID: 21740357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In silico evolutionary dynamics of tumour virotherapy.
    Reis CL; Pacheco JM; Ennis MK; Dingli D
    Integr Biol (Camb); 2010 Jan; 2(1):41-5. PubMed ID: 20473411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent clinical experience with oncolytic viruses.
    Donnelly OG; Errington-Mais F; Prestwich R; Harrington K; Pandha H; Vile R; Melcher AA
    Curr Pharm Biotechnol; 2012 Jul; 13(9):1834-41. PubMed ID: 21740364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer and viruses: a double-edged sword.
    Butt AQ; Miggin SM
    Proteomics; 2012 Jul; 12(13):2127-38. PubMed ID: 22623378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advance in herpes simplex viruses for cancer therapy.
    Liu S; Dai M; You L; Zhao Y
    Sci China Life Sci; 2013 Apr; 56(4):298-305. PubMed ID: 23564184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double trouble for tumours: exploiting the tumour microenvironment to enhance anticancer effect of oncolytic viruses.
    De Silva N; Atkins H; Kirn DH; Bell JC; Breitbach CJ
    Cytokine Growth Factor Rev; 2010; 21(2-3):135-41. PubMed ID: 20338801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted and armed oncolytic poxviruses for cancer: the lead example of JX-594.
    Breitbach CJ; Thorne SH; Bell JC; Kirn DH
    Curr Pharm Biotechnol; 2012 Jul; 13(9):1768-72. PubMed ID: 21740365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational modeling approaches to studying the dynamics of oncolytic viruses.
    Wodarz D
    Math Biosci Eng; 2013 Jun; 10(3):939-57. PubMed ID: 23906157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pro-oncogenic cell signaling machinery as a target for oncolytic viruses.
    Borrego-Diaz E; Mathew R; Hawkinson D; Esfandyari T; Liu Z; Lee PW; Farassati F
    Curr Pharm Biotechnol; 2012 Jul; 13(9):1742-9. PubMed ID: 21740363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. To Infection and Beyond: The Multi-Pronged Anti-Cancer Mechanisms of Oncolytic Viruses.
    Cassady KA; Haworth KB; Jackson J; Markert JM; Cripe TP
    Viruses; 2016 Feb; 8(2):. PubMed ID: 26861381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced killing of therapy-induced senescent tumor cells by oncolytic measles vaccine viruses.
    Weiland T; Lampe J; Essmann F; Venturelli S; Berger A; Bossow S; Berchtold S; Schulze-Osthoff K; Lauer UM; Bitzer M
    Int J Cancer; 2014 Jan; 134(1):235-43. PubMed ID: 23797800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.